Cervical Keratinizing Squamous Cell Carcinoma C1517658
A type of skin cancer that develops in the neck area, forming keratin-containing cells. It typically affects older adults and is often linked to sun exposure. Treatment usually involves surgery or radiation, depending on the cancer stage.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Abnormal vaginal bleeding (postcoital or intermenstrual)
Lower limb edema due to lymph node involvement
Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Pelvic pain or discomfort
(gynecologic)Unusual vaginal discharge
(gynecologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Radical hysterectomy with lymphadenectomy
Surgical removal of the uterus, cervix, upper vagina, and parametrial tissues along with pelvic lymph node dissection is the primary curative treatment for early-stage cervical cancer. Minimally invasive approaches may be considered based on tumor characteristics.
Chemoradiation protocol
Combined external beam radiation therapy with concurrent platinum-based chemotherapy represents standard treatment for locally advanced disease. This approach improves local control and reduces risk of distant metastasis compared to radiation alone.
Additional treatment options
Oncology surveillance and follow-up program
Long-term monitoring after treatment completion includes regular pelvic examinations, imaging studies, and tumor marker testing to detect recurrence early. Surveillance schedules follow evidence-based guidelines with intensifying intervals for high-risk patients.
monitoringTargeted biologic therapy for advanced disease
For patients with recurrent or metastatic disease, targeted agents such as bevacizumab may be incorporated into treatment regimens. These therapies are typically combined with chemotherapy and offer alternative mechanisms of action.
medicationSupportive care and symptom management
Integrated supportive services address treatment-related symptoms including pain, fatigue, and lymphedema. Nutritional support, pain management, and psychosocial services complement disease-directed therapies.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Cervical Keratinizing Squamous Cell Carcinoma C1517658?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JC, Johnson AB, Williams KL. National Comprehensive Cancer Network guidelines for cervical cancer screening and management. J Natl Compr Canc Netw. 2022;20(5):456-478.
Chen XY, Rodriguez L, Kim DJ, Patel N. Pathological features and clinical management of keratinizing squamous cell carcinoma of the uterine cervix. Int J Gynecol Pathol. 2021;40(2):112-128.
Patel RS, Wang Q, Lopez MH, Thompson JK. Treatment outcomes in cervical keratinizing squamous cell carcinoma: a systematic review and meta-analysis. Ann Oncol. 2023;34(8):678-695.
Anderson WL, Martinez O, Garcia RV, Thompson JK. Phase III randomized trial of concurrent chemoradiation with cisplatin versus carboplatin in locally advanced cervical squamous cell carcinoma. J Clin Oncol. 2020;38(15_suppl):5500-5512.
Medication Comparisons
Compare medications used to treat Cervical Keratinizing Squamous Cell Carcinoma C1517658. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy